AgraQuest, Alpharma Animal Health Pair Up For Supply Agreement

AgraQuest and Alpharma Animal Health have agreed to terms for a supply agreement in which AgraQuest will supply their strain of Bacillus subtilis. This input will be used as a key ingredient in a new poultry nutrition product under development by Alpharma.

Layne Asay, director of Strategic Marketing, Alpharma, said: “This agreement supports our efforts to develop and commercialise novel technologies to address a variety of health challenges, improve animal performance and help ensure the safety of food. Alpharma has always been committed to providing the world with a safe, abundant and affordable food supply, and we are pleased to be able to work with AgraQuest as a partner in achieving that goal.”

Mike Miille, president and COO of AgraQuest and head of AgraQuest’s BioInnovations division, said: “Our team has long known that we have developed technologies that have practical applications in segments other than agrochemicals. We are very excited about our relationship with Alpharma.”